LBRX
LB Pharmaceuticals Inc
44.71
-0.23 (-0.51%)
52w low 14.40
50.16 high
84.8% of range
Financial Analysis
| Ratio | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on Equity | 4.7% | -1.1% | -3.8% | -5.0% | -15.5% | |
| Return on Assets | -25.3% | -1.1% | -3.7% | -4.8% | -14.3% | |
| Return on Inv Capital | 4.7% | -1.7% | -4.6% | -5.8% | -16.2% | |
| Liquidity | ||||||
| Current Ratio | 3.78x | 47.60x | 41.44x | 35.68x | 15.08x | |
| Quick Ratio | 3.78x | 47.60x | 41.44x | 35.68x | 15.08x | |
| Cash Ratio | 3.64x | 40.58x | 33.62x | 29.40x | 12.01x | |
| Leverage | ||||||
| Debt / Equity | -0.04x | 0.01x | 0.01x | 0.01x | 0.02x | |
| Equity Multiplier | -0.19x | 1.03x | 1.04x | 1.04x | 1.09x | |
| Efficiency | ||||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | |
| Op CF / Net Income | 1.15x | 0.95x | 1.58x | 1.22x | 0.73x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--